Latest Impairment News

Orica Limited reported a 6% increase in revenue to AUD 8.14 billion and a 23% rise in EBIT to AUD 992.2 million for FY2025, alongside record safety performance and significant strides in decarbonisation.

Control Bionics has integrated Apple’s Brain-Computer Interface protocol into its NeuroNode products, promising simpler setup and enhanced communication for users with severe impairments.

Commonwealth Bank of Australia reported a 2% increase in cash NPAT to approximately $2.6 billion for 1Q26, supported by lending and deposit growth despite margin pressures and rising expenses.

Dyno Nobel reports a robust FY25 with a 23% rise in EBIT excluding major one-offs, nearing completion of its Fertilisers business separation and setting ambitious new decarbonisation targets.

NexGen Energy Ltd. reported a significant net loss for the nine months ended September 30, 2025, driven by mark-to-market losses on convertible debentures and impairment charges. The company bolstered its liquidity with a $953 million equity raise post-period.

ANZ reported a 10% decline in statutory profit for FY2025, impacted by significant regulatory and restructuring charges, while reaffirming its ANZ 2030 strategy and maintaining a strong capital position.

ANZ Group Holdings reported a 10% decline in cash profit for FY2025 despite an 8% rise in operating income, maintaining its dividend amid significant restructuring and regulatory costs.

Macquarie Group Limited reported a 3% increase in net profit to A$1.655 billion for the half year ended 30 September 2025, driven by robust performances in its asset management and capital segments. The Group’s diversified funding and strong capital position underpin its strategic growth and climate finance initiatives.

Macquarie Group Limited reported a 3% increase in profit for the half year ended 30 September 2025, driven by strong performances in asset management and capital advisory, while declaring a 35% franked interim dividend of $2.80 per share.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.

National Australia Bank reported a 1% increase in underlying profit for FY25, with strong deposit growth and higher credit impairment charges marking the year. The bank maintained solid capital ratios and announced an 85 cent fully franked dividend.

National Australia Bank reported a 1% increase in underlying profit for FY25 with stable cash earnings and a steady fully franked dividend of 85 cents per share. The bank’s refreshed strategy shows early momentum despite rising credit impairment charges.